Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000456407 | SCV000564006 | pathogenic | Lynch syndrome | 2016-06-05 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 5-9 of the PMS2 gene. This creates a premature translational stop signal and is expected to result in an absent or disrupted protein product. Truncating variants in PMS2 are known to be pathogenic. This particular truncation has been reported in the literature in an individual affected with colon cancer (PMID: 20205264). For these reasons, this variant has been classified as Pathogenic. |